SCHEMBL851498

SCHEMBL851498

COc1ccc(NNc2ccc(OC)cc2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.70
GAA P10253 3/20 0.70
MAPT P10636 3/20 0.70
NPC1 O15118 3/20 0.70
MAPK1 P28482 2/20 0.70
TDP1 Q9NUW8 2/20 0.70
KDM4E B2RXH2 1/20 0.70
THRB P10828 1/20 0.70
RECQL P46063 1/20 0.70
NPSR1 Q6W5P4 1/20 0.70
L3MBTL1 Q9Y468 1/20 0.70
CA1 P00915 3/20 0.65
CA2 P00918 3/20 0.65
CA7 P43166 2/20 0.65
CA9 Q16790 2/20 0.65
CA12 O43570 1/20 0.65
CA14 Q9ULX7 1/20 0.65
SMN1; SMN2 Q16637 2/20 0.56
NR4A1 P22736 1/20 0.56
ALDH1A1 P00352 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4909838 0.90 CYP1A2 (0.62) RAB9AGAAMAPTNPC1MAPK1
SCHEMBL3967781 0.90 ACHE (0.71) RAB9AGAAMAPTNPC1MAPK1
SCHEMBL22931133 0.88 NR4A1 (0.76) RAB9AGAAMAPTNPC1MAPK1
SCHEMBL903659 0.87 RAB9A (0.61) RAB9AGAAMAPTNPC1MAPK1
SCHEMBL14104849 0.86 CTSD (0.61) RAB9AGAAMAPTNPC1MAPK1
Hydrochloric Acid SCHEMBL6232337 0.85 GAA (0.58) RAB9AGAAMAPTNPC1MAPK1
SCHEMBL8359254 0.85 MAPT (0.58) RAB9AGAAMAPTNPC1MAPK1
SCHEMBL8581249 0.85 GAA (0.58) RAB9AGAAMAPTNPC1MAPK1
SCHEMBL8216660 0.84 LTA4H (0.75) RAB9AGAAMAPTNPC1MAPK1
SCHEMBL6889056 0.84 MAPT (0.58) RAB9AGAAMAPTNPC1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9932300-B2 N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2018-04-03 US disclosed
US-20160318857-A1 N,N'-Diarylurea Compounds and N,N'-Diarylthiourea Compounds as Inhibitors of Translation Initiation PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2016-11-03 US disclosed
US-9421211-B2 N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2016-08-23 US disclosed
US-20120115915-A1 N,N'-DIARYLUREA COMPOUNDS AND N,N'-DIARYLTHIOUREA COMPOUNDS AS INHIBITORS OF TRANSLATION INITIATION PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-05-10 US disclosed
EP-2243806-B1 METHOD OF PRODUCING AN AQUEOUS DISPERSION OF SURFACE-TREATED CARBON BLACK TOKAI CARBON KK (JP) 2012-03-28 EP disclosed
US-20110253008-A1 AQUEOUS DISPERSION OF SURFACE-TREATED CARBON BLACK AND METHOD OF PRODUCING THE SAME TOKAI CARBON CO., LTD. 2011-10-20 US disclosed
US-8026370-B2 Peroxisome proliferator antagonist; hyperlipemia agents; arteriosclerosis; antiischemic agents MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-09-27 US disclosed
US-20100269732-A1 AQUEOUS DISPERSION OF SURFACE-TREATED CARBON BLACK AND METHOD OF PRODUCING THE SAME TOKAI CARBON CO., LTD. (JP) 2010-10-28 US disclosed
EP-2243806-A1 AQUEOUS DISPERSION OF SURFACE-TREATED CARBON BLACK AND METHOD OF PRODUCING THE SAME Tokai Carbon Co., Ltd. (JP) 2010-10-27 EP disclosed
US-20080269420-A1 Shape Memory Epoxy Copolymer CORNERSTONE RESEARCH GROUP, INC. 2008-10-30 US disclosed
US-5874443-A BIOSYNTHESIS TREGA BIOSCIENCES, INC. (US) 1999-02-23 US disclosed
EP-0692033-B1 ENHANCEMENT OF CHEMILUMINESCENT REACTIONS BRITISH TECH GROUP (GB) 1998-03-11 EP disclosed
US-5512451-A MIXTURE OF A AROMATIC DIACYL CYCLIC HYDRAZIDE, PEROXIDASE CATALYST AND OXIDIZER BRITISH TECHNOLOGY GROUP LIMITED (GB) 1996-04-30 US disclosed
WO-1994023060-A2 ENHANCEMENT OF CHEMILUMINESCENT REACTIONS BRITISH TECHNOLOGY GROUP LIMITED (GB) 1994-10-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160318857-A1 N,N'-Diarylurea Compounds and N,N'-Diarylthiourea Compounds as Inhibitors of Translation Initiation NSUN2, EIF2AK2, RNGTT RAB9A 2490/4885GAA 2514/4885MAPT 1631/4885
US-20120115915-A1 N,N'-DIARYLUREA COMPOUNDS AND N,N'-DIARYLTHIOUREA COMPOUNDS AS INHIBITORS OF TRANSLATION INITIATION NSUN2, EIF2AK2, RNGTT RAB9A 2490/4885GAA 2514/4885MAPT 1631/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.